A method, device, and medium for controlling the inflation and deflation of a therapeutic instrument.
By using a gradual inflation and deflation method and real-time monitoring and control of the intracavitary pressure, the discomfort caused by sudden pressure stimulation in air wave therapy is solved, achieving a safer and more comfortable treatment effect.
Patent Information
- Application Number
- CN202310855079.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-07-12
- Publication Date
- 2025-11-14
- Estimated Expiration
- 2043-07-12
AI Technical Summary
Existing air wave pressure therapy devices can cause discomfort or injury to users due to sudden pressure stimulation during air wave therapy.
The pressure inside the cavity is controlled by a gradual, gradient inflation and deflation method, including gradually increasing the pressure to the preset value at a preset inflation rate, constant pressure treatment, and gradually decreasing the pressure to zero at a preset deflation rate. The inflation rate and pressure value are adjusted in conjunction with real-time monitoring of the user's physiological indicators and the pressure inside the cavity.
It reduces the probability of users experiencing discomfort or damage due to mutation stress stimulation, and improves the comfort and safety of treatment.
Smart Images

Figure CN116898709B_ABST
Abstract
Description
Technical Field
[0001] This application relates to the field of air wave pressure technology, and in particular to a method, device and medium for controlling the inflation and deflation of a therapeutic instrument. Background Technology
[0002] Air wave pressure therapy devices mainly create circulatory pressure on limbs and tissues by sequentially and repeatedly inflating and deflating multi-chamber airbags. This provides uniform and orderly compression from the distal to the proximal end of the limb, promoting blood and lymph flow and improving microcirculation. It also accelerates the return of tissue fluid to the limbs, helping to prevent thrombosis and limb edema. It can directly or indirectly prevent or treat many diseases related to blood and lymphatic circulation.
[0003] Current air wave pressure therapy devices use a one-step controlled inflation method to control the pressure inside the cavity during air wave pressure therapy. The treatment is performed according to the preset pressure from the beginning to the end. However, sudden pressure stimulation can easily cause discomfort or injury to the user.
[0004] Therefore, reducing the probability of users experiencing discomfort or damage due to mutation stress is a problem that urgently needs to be solved by those skilled in the art. Summary of the Invention
[0005] The purpose of this application is to provide a method, device, and medium for controlling the inflation and deflation of a therapeutic instrument, so as to avoid sudden pressure stimulation during air wave therapy in the current technology and reduce the probability of discomfort or injury to the user due to sudden pressure stimulation.
[0006] To solve the above-mentioned technical problems, this application provides a method for controlling the inflation and deflation of a therapeutic instrument, comprising:
[0007] Upon receiving the inflation command, the internal pressure is gradually increased to the preset pressure value according to the preset inflation speed;
[0008] After the intracavitary pressure reaches the preset pressure value, constant pressure treatment is performed according to the preset pressure value for a preset time.
[0009] After the constant pressure treatment time reaches the preset time, the intracavitary pressure is gradually reduced from the preset pressure value to zero according to the preset deflation rate.
[0010] Preferably, the preset inflation speed is calculated as follows:
[0011]
[0012] Wherein, Pstep is the preset inflation speed, P is the preset pressure value, and T(S1) is the time required for the intracavity pressure to increase to the preset pressure value.
[0013] Preferably, the preset inflation speed value is equal to the preset deflation speed value.
[0014] Preferred options also include:
[0015] Obtain user physiological indicator information; the physiological indicator information includes blood oxygen, heart rate, and pulse rate;
[0016] If any of the physiological indicators is detected to have a change exceeding the corresponding threshold, the treatment process will be stopped and the intracavitary pressure will be reduced to zero.
[0017] Preferred options also include:
[0018] Determine whether the physiological indicators have recovered to the normal range of change within a preset time;
[0019] If so, the preset pressure value in the calculation method of the preset inflation speed is reduced to one-half, and the second inflation speed is calculated.
[0020] Correspondingly, the pressure inside the cavity is gradually increased to the preset pressure value according to the second inflation speed.
[0021] Preferably, the physiological indicator information also includes blood refill time;
[0022] Further, determine whether the blood refill time exceeds a time threshold;
[0023] If so, the preset pressure value is reduced to the target pressure value according to a preset percentage until the blood refill time does not exceed the time threshold.
[0024] Preferred options also include:
[0025] Monitor whether the inflation pressure inside the cavity exceeds the allowable range;
[0026] If so, deflate the gas until it drops to the acceptable range.
[0027] To address the aforementioned technical problems, this application also provides a gas inflation / deflation control device for a therapeutic instrument, comprising:
[0028] The inflation module is used to gradually increase the internal pressure to the preset pressure value according to the preset inflation speed after receiving the inflation command;
[0029] The constant pressure module is used to perform constant pressure treatment based on the preset pressure value after the intracavitary pressure reaches the preset pressure value and to continue for a preset time.
[0030] The deflation module is used to gradually reduce the intracavitary pressure from the preset pressure value to zero according to the preset deflation rate after the constant pressure treatment time reaches the preset time.
[0031] To solve the above-mentioned technical problems, this application also provides another gas filling and deflating control device for a therapeutic instrument, including a memory for storing computer programs;
[0032] A processor is used to implement the steps of the above-described method for controlling the inflation and deflation of a therapeutic instrument when executing the computer program.
[0033] To address the aforementioned technical problems, this application also provides a computer-readable storage medium storing a computer program, which, when executed by a processor, implements the steps of the above-described method for controlling the inflation and deflation of a therapeutic instrument.
[0034] The inflation / deflation control method for the therapeutic device provided in this application, upon receiving an inflation command, gradually increases the intracavitary pressure to a preset pressure value according to a preset inflation rate. After the intracavitary pressure reaches the preset pressure value, constant pressure treatment is performed based on the preset pressure value for a preset time. After the constant pressure treatment time reaches the preset time, the intracavitary pressure is gradually reduced from the preset pressure value to zero according to a preset deflation rate. Compared to current technologies, where intracavitary pressure is controlled in a one-step manner during air wave pressure therapy, and treatment is performed at a preset pressure from start to finish, sudden pressure stimulation can easily cause discomfort or injury to the user. This technical solution, however, inflates and deflates the intracavitary pressure at a preset rate, using a gradual, gradient inflation / deflation method to control the pressure value during inflation. This allows the user to gradually adapt to the corresponding pressure stimulation intensity, reducing the probability of discomfort or injury caused by sudden pressure stimulation.
[0035] Furthermore, the gas filling and deflating control device and medium provided in this application correspond to the aforementioned gas filling and deflating control method for the therapeutic instrument, and have the same effect. Attached Figure Description
[0036] To more clearly illustrate the embodiments of this application, the accompanying drawings used in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of this application. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.
[0037] Figure 1 A flowchart illustrating a method for controlling the inflation and deflation of a therapeutic instrument, as provided in this application embodiment;
[0038] Figure 2 A structural diagram of a gas inflation / deflation control device for a therapeutic instrument provided in this application embodiment;
[0039] Figure 3This is a structural diagram of another gas filling and deflating control device for a therapeutic instrument provided in an embodiment of this application. Detailed Implementation
[0040] The technical solutions of the embodiments of this application will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of this application, and not all embodiments. Based on the embodiments of this application, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the protection scope of this application.
[0041] The core of this application is to provide a method, device, and medium for controlling the inflation and deflation of a therapeutic instrument, which can avoid sudden pressure stimulation during air wave therapy in the current technology and reduce the probability of discomfort or injury to the user due to sudden pressure stimulation.
[0042] To enable those skilled in the art to better understand the present application, the present application will be further described in detail below with reference to the accompanying drawings and specific embodiments.
[0043] Figure 1 A flowchart of a method for controlling the inflation and deflation of a therapeutic device provided in this application embodiment is shown below. Figure 1 As shown, the inflation / deflation control method of this therapeutic device includes:
[0044] S10: After receiving the inflation command, gradually increase the pressure inside the cavity to the preset pressure value according to the preset inflation speed;
[0045] S11: After the intracavitary pressure reaches the preset pressure value, constant pressure treatment is performed according to the preset pressure value and continues for a preset time;
[0046] S12: After the constant pressure treatment time reaches the preset time, the intracavitary pressure is gradually reduced from the preset pressure value to zero according to the preset deflation rate.
[0047] The inflation / deflation control method for the therapeutic device provided in this application is mainly applied to air wave pressure therapy devices. In specific implementation, the executing entity can be the inflation / deflation control device of the therapeutic device, specifically a processor, etc., which achieves treatment by inflating and deflating the cavities. An air wave pressure therapy device, also called a pressure antithrombotic pump, is a medical device used to prevent and treat deep vein thrombosis. An air wave pressure therapy device typically consists of one or more cavities, which are air bags used for inflation. These cavities are sequentially inflated or deflated within a predetermined time. When the cavities are inflated, they apply pressure, causing the surrounding muscles and blood vessels to contract, thereby promoting blood flow. When the gas is released from the cavities, the surrounding muscles and blood vessels relax, allowing more blood to flow into the lower limbs. This intermittent pressure stimulation can help promote blood circulation in the lower limbs, thereby reducing the risk of venous thrombosis. Air wave pressure therapy devices mainly create circulatory pressure on limbs and tissues by sequentially and repeatedly inflating and deflating multi-chamber airbags. This provides uniform and orderly compression from the distal to the proximal end of the limb, promoting blood and lymph flow and improving microcirculation. It also accelerates the return of tissue fluid to the limbs, helping to prevent thrombosis and limb edema. It can directly or indirectly prevent or treat many diseases related to blood and lymphatic circulation.
[0048] This application primarily employs a gradual, gradient inflation and deflation method to inflate and deflate the cavity, controlling the pressure value during inflation. This allows the user to gradually adapt to the corresponding pressure stimulation, reducing the probability of discomfort or injury due to sudden pressure stimulation. In specific implementation, air wave pressure therapy can be divided into an inflation phase, a constant pressure phase, and a deflation phase. The inflation and deflation control method provided in this application targets pressure control during the treatment process, specifically controlling the pressure within the cavity. In this application, during the inflation phase, the intracavitary pressure is gradually increased to a preset pressure value according to a preset inflation rate. During the constant pressure phase, the intracavitary pressure is maintained at a preset pressure value for a preset duration. During the deflation phase, the intracavitary pressure is gradually reduced from the preset pressure value to zero according to a preset deflation rate. In this application, the inflation phase, constant pressure phase, and deflation phase together constitute the treatment time. Since this application controls the intracavitary pressure, this technical solution can be used regardless of whether the treatment device adopts a periodic or cyclic mode. It is understandable that the phased inflation and deflation method is mainly to avoid discomfort or injury to the user caused by sudden pressure stimulation. Therefore, the constant pressure treatment time should be longer than the time required for the inflation and deflation phases.
[0049] The inflation / deflation control method for the therapeutic device provided in this application, upon receiving an inflation command, gradually increases the intracavitary pressure to a preset pressure value according to a preset inflation rate. After the intracavitary pressure reaches the preset pressure value, constant pressure treatment is performed based on the preset pressure value for a preset time. After the constant pressure treatment time reaches the preset time, the intracavitary pressure is gradually reduced from the preset pressure value to zero according to a preset deflation rate. Compared to the current technology, where the intracavitary pressure is controlled in a one-step manner during air wave pressure therapy, and the treatment is performed according to a preset pressure from start to finish, sudden pressure stimulation can easily cause discomfort or injury to the user. This technical solution, however, inflates and deflates the intracavitary pressure at a preset rate, using a gradual, gradient inflation / deflation method to control the pressure value during inflation, allowing the user to gradually adapt to the corresponding pressure stimulation intensity, and reducing the probability of discomfort or injury due to sudden pressure stimulation.
[0050] In practice, since the treatment time consists of three parts—inflation / deflation and constant pressure—all of which contribute to the therapeutic effect, the time required for each stage should be rationally allocated based on the desired therapeutic effect and treatment duration. Let the total treatment time be T, where T(S1) is the time required for the inflation stage, T(S2) is the time required for the constant pressure stage, and T(S3) is the time required for the deflation stage. In practice, to achieve a stable and gradual inflation effect, the preset inflation speed can be set according to the treatment duration and the required intracavitary pressure value. Specifically, the preset inflation speed is calculated as follows:
[0051]
[0052] Where Pstep is the preset inflation speed, P is the preset pressure value, and T(S1) is the time required for the internal pressure to increase to the preset pressure value. The unit of T(S1) is usually minutes.
[0053] As can be seen, in this embodiment, the inflation speed inside the cavity is set based on the inflation duration and the preset pressure value. During the S1 inflation stage, the pressure increase per minute, i.e., the pressure step, is... That is, the pressure value to be reached in the first minute is P1 = Pstep, the pressure value to be reached in the second minute is P2 = P1 + Pstep, and for each additional minute thereafter, the pressure needs to increase by Pstep compared to the previous minute, until the pressure increases to P. In stage S2, each inflation reaches P and is maintained for a certain period of time according to the current pattern. In practical implementation, to improve user comfort, the preset inflation speed can be equal to the preset deflation speed, so that the inflation and deflation phases are performed at the same speed to improve user comfort. Specifically, the pressure decrease value in stage S3 is... The process is the same as step S1, except that for each additional minute, the pressure value to be reached during inflation is reduced by Pstep from the previous time point.
[0054] This application employs a gradual approach to allow users to adapt to the changes in air wave pressure during treatment in a step-by-step manner, enabling the body to gradually adapt to this pressure stimulation. Similarly, at the end of the treatment, the body gradually returns to a state of calm, which can greatly reduce the discomfort or damage caused to users by sudden pressure stimulation.
[0055] In practical implementation, assume the time for the three stages is allocated according to S1:S2:S3 = 1:3:1. The time required for stage S1 is... S2 phase time The time for stage S3 is
[0056]
[0057] The above embodiments describe the control of intracavitary pressure during routine treatment. However, in practice, due to differences in the user's physical condition, gender, and environment, even though the above embodiments have gradually adapted the user to the pressure stimulation, the pressure during treatment may still cause discomfort or injury. Therefore, in order to monitor the user's condition in real time and avoid damage to the user from intracavitary pressure, in this embodiment, the inflation and deflation control method of the treatment device further includes:
[0058] Obtain user physiological indicators; these include blood oxygen saturation, heart rate, and pulse rate.
[0059] If any change in any of the physiological indicators exceeds the corresponding threshold, the treatment process will be stopped and the intracavitary pressure will be reduced to zero.
[0060] In this embodiment, the user's physical health status is mainly reflected by blood oxygen, heart rate, and pulse rate. These parameters can be collected using existing technologies such as electrocardiogram (ECG) devices and pulse oximetry devices. The detection of physiological indicators primarily involves checking for abrupt changes. If any change in any of the physiological indicators exceeds a corresponding threshold, it indicates an abnormality in the user's physical condition. In this case, to avoid further harm, treatment should be immediately stopped, and the intracavitary pressure reduced to zero.
[0061] In other embodiments, there may be situations where there is poor contact between the detection device and the user, or sudden changes in physiological indicator information. In such cases, different thresholds can be set for the changes in the indicator values, namely a first threshold for poor contact and a second threshold for user discomfort, in order to distinguish between user discomfort and poor device contact.
[0062] It is understandable that when abnormal changes in the physiological indicators mentioned in the above embodiments occur, it often indicates that the user is still unable to adapt to the current inflation speed. Therefore, in order to achieve treatment, the inflation speed can be slowed down and the inflation time increased. In this embodiment, the inflation and deflation control method of the therapeutic device further includes:
[0063] Determine whether the physiological indicators have returned to the normal range within a preset time;
[0064] If so, the preset pressure value in the preset inflation speed calculation method is reduced to half, and the second inflation speed is calculated.
[0065] Correspondingly, the pressure inside the cavity is gradually increased to the preset pressure value according to the second inflation speed.
[0066] As can be seen, in this embodiment, the pressure value was reduced when calculating the pressure step value, thereby extending the inflation time and making it easier for users to adapt to the pressure during inflation.
[0067] Specifically, based on the examples provided in the above embodiments, for instance, if any of the monitored physiological indicators—blood oxygen saturation ΔPO2, pulse rate ΔPr, and heart rate ΔHr—exceeds the normal range, the processor immediately controls the deflation and determines in real time whether the indicators return to the normal range within a certain time. If they do, the program automatically reduces the preset pressure value P to P / 2 and gradually increases the pressure. For each pressure increase, the current pressure is maintained for a time ΔT to allow the patient to adapt before gradually increasing the pressure to P. The time used for this escalation phase is: Since the hold time is increased during the rise phase, the time of phase S2 is correspondingly reduced. The calculated duration of phase S2 in this process is: The S3 stage is the same as the S1 stage of the same process. In this embodiment, by monitoring human vital signs parameters in real time and adjusting the actual output value of air wave pressure in real time, the safety of the patient is protected to the greatest extent and the secondary damage caused by air wave therapy is reduced.
[0068] Based on the above embodiments, in this embodiment, the physiological indicator information also includes blood refill time;
[0069] Furthermore, determine whether the blood refill time exceeds the time threshold;
[0070] If so, the preset pressure value will be reduced to the target pressure value according to the preset percentage until the blood recovery time does not exceed the time threshold.
[0071] Blood refill testing is a simple, non-invasive method used to assess lower limb venous function and hemodynamics. In this embodiment, in addition to detecting the user's blood oxygen saturation, heart rate, and pulse rate, the blood refill time is also monitored to further ensure user safety. In this embodiment, the user's blood refill time is monitored in real time. When the blood refill time exceeds a time threshold, a preset pressure value is reduced, and the inflation rate is readjusted. Specifically, this can be done according to certain rules, such as reducing the pressure by a percentage of the preset value, until the blood refill time returns to the normal range.
[0072] In practical implementation, the control of the intracavitary pressure should be carried out in the form of feedback to ensure that the intracavitary pressure remains within a stable range during the constant pressure stage and the inflation stage. Therefore, in this embodiment, it also includes:
[0073] Monitor whether the inflation pressure inside the cavity exceeds the allowable range;
[0074] If so, deflate the gas until it drops to the acceptable range.
[0075] In this embodiment, for safety, the application also monitors in real time whether the inflation pressure exceeds the upper limit value. If the program detects that the current pressure exceeds the upper limit value, it will immediately deflate and determine in real time whether the pressure value drops to the allowable range, and continue the current treatment until it drops to the allowable range.
[0076] In the above embodiments, the method for controlling the inflation and deflation of the therapeutic instrument has been described in detail. This application also provides embodiments corresponding to the control device for the inflation and deflation of the therapeutic instrument. It should be noted that this application describes the embodiments of the device from two perspectives: one is based on the functional modules, and the other is based on the hardware.
[0077] Figure 2 This application provides a structural diagram of a gas inflation / deflation control device for a therapeutic instrument, as shown in the embodiments below. Figure 2 As shown, the device includes:
[0078] Inflation module 10 is used to gradually increase the pressure inside the cavity to a preset pressure value according to a preset inflation speed after receiving an inflation command.
[0079] The constant pressure module 11 is used to perform constant pressure treatment according to the preset pressure value after the intracavitary pressure reaches the preset pressure value and continue for a preset time.
[0080] The venting module 12 is used to gradually reduce the intracavitary pressure from the preset pressure value to zero according to the preset venting rate after the constant pressure treatment time reaches the preset time.
[0081] Since the embodiments of the apparatus and the embodiments of the method correspond to each other, please refer to the description of the embodiments of the method for the embodiments of the apparatus, which will not be repeated here.
[0082] The inflation / deflation control device for the therapeutic instrument provided in this application, upon receiving an inflation command, gradually increases the intracavitary pressure to a preset pressure value according to a preset inflation rate. After the intracavitary pressure reaches the preset pressure value, constant pressure treatment is performed based on the preset pressure value for a preset time. After the constant pressure treatment time reaches the preset time, the intracavitary pressure is gradually reduced from the preset pressure value to zero according to a preset deflation rate. Compared to the current technology, where the intracavitary pressure is controlled in a one-step manner during air wave pressure therapy, and the treatment is performed according to a preset pressure from start to finish, sudden pressure stimulation can easily cause discomfort or injury to the user. This technical solution, however, inflates and deflates the intracavitary pressure at a preset rate, using a gradual, gradient inflation / deflation method to control the pressure value during inflation, allowing the user to gradually adapt to the corresponding pressure stimulation intensity, and reducing the probability of discomfort or injury due to sudden pressure stimulation.
[0083] Figure 3 A structural diagram of another gas inflation / deflation control device for a therapeutic instrument provided in this application embodiment is shown below. Figure 3 As shown, the device includes: a memory 20 for storing computer programs;
[0084] The processor 21 is used to execute a computer program to implement the steps of the inflation / deflation control method for the therapeutic instrument as described in the above embodiments.
[0085] The inflation / deflation control device for the therapeutic instrument provided in this embodiment may include, but is not limited to, smartphones, tablets, laptops, or desktop computers.
[0086] The processor 21 may include one or more processing cores, such as a quad-core processor or an octa-core processor. The processor 21 may be implemented using at least one of the following hardware forms: Digital Signal Processor (DSP), Field-Programmable Gate Array (FPGA), or Programmable Logic Array (PLA). The processor 21 may also include a main processor and a coprocessor. The main processor, also known as the Central Processing Unit (CPU), is used to process data in the wake-up state; the coprocessor is a low-power processor used to process data in the standby state. In some embodiments, the processor 21 may integrate a Graphics Processing Unit (GPU), which is responsible for rendering and drawing the content to be displayed on the screen. In some embodiments, the processor 21 may also include an Artificial Intelligence (AI) processor, which is used to handle computational operations related to machine learning.
[0087] The memory 20 may include one or more computer-readable storage media, which may be non-transitory. The memory 20 may also include high-speed random access memory and non-volatile memory, such as one or more disk storage devices or flash memory devices. In this embodiment, the memory 20 is used to store at least the following computer program 201, which, after being loaded and executed by the processor 21, is capable of implementing the relevant steps of the inflation / deflation control method of the therapeutic instrument disclosed in any of the foregoing embodiments. In addition, the resources stored in the memory 20 may also include an operating system 202 and data 203, and the storage method may be temporary or permanent storage. The operating system 202 may include Windows, Unix, Linux, etc. The data 203 may include, but is not limited to, preset pressure values.
[0088] In some embodiments, the inflation / deflation control device of the therapeutic instrument may further include a display screen 22, an input / output interface 23, a communication interface 24, a power supply 25, and a communication bus 26.
[0089] Those skilled in the art will understand that Figure 3 The structure shown does not constitute a limitation on the inflation / deflation control device of the therapeutic instrument, and may include more or fewer components than shown.
[0090] The inflation / deflation control device for the therapeutic instrument provided in this application includes a memory and a processor. When the processor executes the program stored in the memory, it can perform the following method: after receiving an inflation command, it gradually increases the intracavitary pressure to a preset pressure value according to a preset inflation speed; after the intracavitary pressure reaches the preset pressure value, it performs constant pressure treatment according to the preset pressure value and continues for a preset time; after the constant pressure treatment time reaches the preset time, it gradually reduces the intracavitary pressure from the preset pressure value to zero according to a preset deflation speed.
[0091] Finally, this application also provides an embodiment corresponding to a computer-readable storage medium. The computer-readable storage medium stores a computer program, which, when executed by a processor, implements the steps described in the above method embodiments.
[0092] It is understood that if the methods in the above embodiments are implemented as software functional units and sold or used as independent products, they can be stored in a computer-readable storage medium. Based on this understanding, the technical solution of this application, in essence, or the part that contributes to the prior art, or all or part of the technical solution, can be embodied in the form of a software product. This computer software product is stored in a storage medium and executes all or part of the steps of the methods described in the various embodiments of this application. The aforementioned storage medium includes various media capable of storing program code, such as USB flash drives, portable hard drives, read-only memory (ROM), random access memory (RAM), magnetic disks, or optical disks.
[0093] The above provides a detailed description of the inflation / deflation control method, apparatus, and medium for the therapeutic instrument provided in this application. The various embodiments in the specification are described in a progressive manner, with each embodiment focusing on its differences from other embodiments. Similar or identical parts between embodiments can be referred to interchangeably. For the apparatus disclosed in the embodiments, since it corresponds to the method disclosed in the embodiments, the description is relatively simple; relevant parts can be referred to in the method section. It should be noted that those skilled in the art can make several improvements and modifications to this application without departing from the principles of this application, and these improvements and modifications also fall within the protection scope of the claims of this application.
[0094] It should also be noted that, in this specification, relational terms such as "first" and "second" are used only to distinguish one entity or operation from another, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Furthermore, the terms "comprising," "including," or any other variations thereof are intended to cover non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements includes not only those elements but also other elements not expressly listed, or elements inherent to such a process, method, article, or apparatus. Without further limitations, an element defined by the phrase "comprising one..." does not exclude the presence of other identical elements in the process, method, article, or apparatus that includes said element.
Claims
1. A gas inflation / deflation control device for a therapeutic instrument, characterized in that, include: The inflation module is used to gradually increase the internal pressure to the preset pressure value according to the preset inflation speed after receiving the inflation command; The constant pressure module is used to perform constant pressure treatment based on the preset pressure value after the intracavitary pressure reaches the preset pressure value and to continue for a preset time. The deflation module is used to gradually reduce the intracavitary pressure from the preset pressure value to zero according to the preset deflation rate after the constant pressure treatment time reaches the preset time. The preset inflation speed is calculated as follows: ; in, To preset inflation speed, For the preset pressure value, The time required for the intracavitary pressure to increase to the preset pressure value; the preset inflation rate value is equal to the preset deflation rate value; The inflation / deflation control device of the therapeutic instrument is also used to acquire the user's physiological index information and adjust the intracavitary pressure based on the physiological index information; the physiological index information includes blood oxygen, heart rate, pulse rate and blood refill time; The adjustment of the intracavitary pressure based on the physiological indicator information includes: If any of the blood oxygen, heart rate, or pulse rate indicators is detected to exceed the corresponding threshold, the treatment process will be stopped and the intracavitary pressure will be reduced to zero. Determine whether the blood oxygen, heart rate, and pulse rate return to normal range within a preset time. If so, the preset pressure value in the calculation method of the preset inflation speed is reduced to one-half, and the second inflation speed is calculated. Correspondingly, the internal pressure is gradually increased to the preset pressure value according to the second inflation speed; Determine whether the blood refill time exceeds a time threshold; If so, the preset pressure value is reduced to the target pressure value according to a preset percentage until the blood refill time does not exceed the time threshold.
2. A gas inflation / deflation control device for a therapeutic instrument, characterized in that, Includes a memory for storing computer programs; and a processor for executing the computer programs to perform the following steps: Upon receiving the inflation command, the internal pressure is gradually increased to the preset pressure value according to the preset inflation speed; After the intracavitary pressure reaches the preset pressure value, constant pressure treatment is performed according to the preset pressure value for a preset time. After the constant pressure treatment time reaches the preset time, the intracavitary pressure is gradually reduced from the preset pressure value to zero according to the preset deflation rate; The preset inflation speed is calculated as follows: ; in, To preset inflation speed, For the preset pressure value, The time required for the intracavitary pressure to increase to the preset pressure value; the preset inflation rate value is equal to the preset deflation rate value; The processor is further configured to execute the computer program to perform the following steps: The system acquires the user's physiological indicators and adjusts the intracavitary pressure based on these indicators; the physiological indicators include blood oxygen, heart rate, pulse rate, and blood refill time. The adjustment of the intracavitary pressure based on the physiological indicator information includes: If any of the blood oxygen, heart rate, or pulse rate indicators is detected to exceed the corresponding threshold, the treatment process will be stopped and the intracavitary pressure will be reduced to zero. Determine whether the blood oxygen, heart rate, and pulse rate return to normal range within a preset time. If so, the preset pressure value in the calculation method of the preset inflation speed is reduced to one-half, and the second inflation speed is calculated. Correspondingly, the internal pressure is gradually increased to the preset pressure value according to the second inflation speed; Determine whether the blood refill time exceeds a time threshold; If so, the preset pressure value is reduced to the target pressure value according to a preset percentage until the blood refill time does not exceed the time threshold.
3. The inflation / deflation control device for the therapeutic instrument according to claim 2, characterized in that, The processor is further configured to execute the computer program to perform the following steps: Monitor whether the inflation pressure inside the cavity exceeds the allowable range; If so, deflate the gas until it drops to the acceptable range.
4. A computer-readable storage medium, characterized in that, The computer-readable storage medium stores a computer program that, when executed by a processor, performs the following steps: Upon receiving the inflation command, the internal pressure is gradually increased to the preset pressure value according to the preset inflation speed; After the intracavitary pressure reaches the preset pressure value, constant pressure treatment is performed according to the preset pressure value for a preset time. After the constant pressure treatment time reaches the preset time, the intracavitary pressure is gradually reduced from the preset pressure value to zero according to the preset deflation rate; The preset inflation speed is calculated as follows: ; in, To preset inflation speed, For the preset pressure value, The time required for the intracavitary pressure to increase to the preset pressure value; the preset inflation rate value is equal to the preset deflation rate value; The processor is further configured to execute the computer program to perform the following steps: The system acquires the user's physiological indicators and adjusts the intracavitary pressure based on these indicators; the physiological indicators include blood oxygen, heart rate, pulse rate, and blood refill time. The adjustment of the intracavitary pressure based on the physiological indicator information includes: If any of the blood oxygen, heart rate, or pulse rate indicators is detected to exceed the corresponding threshold, the treatment process will be stopped and the intracavitary pressure will be reduced to zero. Determine whether the blood oxygen, heart rate, and pulse rate return to normal range within a preset time. If so, the preset pressure value in the calculation method of the preset inflation speed is reduced to one-half, and the second inflation speed is calculated. Correspondingly, the internal pressure is gradually increased to the preset pressure value according to the second inflation speed; Determine whether the blood refill time exceeds a time threshold; If so, the preset pressure value is reduced to the target pressure value according to a preset percentage until the blood refill time does not exceed the time threshold.
Citation Information
Patent Citations
Wearable device for preventing lower limb venous thrombosis
CN110680693A
External counterpulsation pressurization system
CN112206142A